GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | increases expression | ISO | RGD:733985 | 6480464 | CTD | Tretinoin results in increased expression of BCL2A1 mRNA, Tretinoin results in increased expression of BCL2A1A protein | PMID:10673743, PMID:11133770, PMID:12130515, PMID:15498508, PMID:15894607, PMID:16572199 | multiple interactions | ISO | RGD:733985 | 6480464 | CTD | [Tretinoin co-treated with arsenic trioxide co-treated with Butyrates] results in increased expression of BCL2A1 mRNA, [Tretinoin co-treated with arsenic trioxide co-treated with hexamethylene bisacetamide] results in increased expression of BCL2A1 mRNA, [Tretinoin co-treated with arsenic trioxide] results in increased expression of BCL2A1 mRNA, [Tretinoin co-treated with Butyrates] results in increased expression of BCL2A1 mRNA, [Tretinoin co-treated with hexamethylene bisacetamide] results in increased expression of BCL2A1 mRNA, [Tretinoin results in increased expression of BCL2A1 mRNA] which results in decreased susceptibility to Doxorubicin, arsenic trioxide inhibits the reaction [Tretinoin results in increased expression of BCL2A1A protein] | PMID:11133770, PMID:12130515, PMID:15894607, PMID:16572199 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |
